Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Phase 2]
Phase 2 study updating the effect of Zometa on bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Prospective Investigation of Robotic Single-port System [Phase 1, Phase 2]
This clinical trial update reports the completion of a prospective Phase 1/2 study evaluating the Robotic Single-Port System for prostate an…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases [Phase 3]
Phase III trial evaluating Radium-223 dichloride in symptomatic hormone-refractory prostate cancer with skeletal metastases completed; resul…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer [Phase 1]
Phase 1 trial evaluating CP-675,206 in combination with short-term androgen deprivation in stage D0 prostate cancer; trial terminated with r…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer [Phase 1]
A Phase 1 trial update of AGS-1C4D4 in patients with advanced hormone-refractory prostate cancer has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 dose-escalation trial of abiraterone acetate in hormone-refractory prostate cancer, with r…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer [NA]
Study terminated; results posted but no clear efficacy outcomes reported. Focused on endoscopic evaluation of late rectal injury after Cyber…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy [Phase 1]
Phase 1 safety study of repeated dosing with a cytotoxic lymphocyte–based therapy for hormone-refractory prostate cancer, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy [NA]
This update reports the completion of a clinical trial evaluating the health effects of soccer training in men with prostate cancer receivin…
-
FDA approval · 2014-04-17FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer [Phase 2]
Phase 2 clinical trial of Kanglaite Gelcaps for prostate cancer has been terminated; the update reports safety and efficacy observations fro…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses [NA]
A completed clinical trial evaluating an exercise-based intervention for prostate cancer survivors and their spouses.
-
CLINICAL_TRIALS withdrawal · 2014-04-10Clinical Trial Update: MR-Guided Laser Ablation of Prostate Bed Recurrences [NA]
The Mayo Clinic-sponsored trial evaluating MR-guided laser ablation for prostate bed recurrences has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer [Phase 2]
A Phase 2 trial comparing neoadjuvant abiraterone plus LHRH therapy to LHRH alone in prostate cancer has completed and posted results in 201…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer [Phase 2]
This ClinicalTrials.gov update reports the termination of a Phase 2 pharmacokinetic and efficacy study of Nordihydroguaiaretic acid (NDGA) i…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy [NA]
A completed randomized trial comparing urinary diversion options after robot-assisted radical prostatectomy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery [NA]
This entry reports the completion of a clinical trial evaluating real-time microscopic imaging during robot-assisted prostate cancer surgery…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer [Phase 2]
Phase 2 study of trabectedin (Yondelis) in adult male participants with advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients [Phase 2]
A Phase 2 study evaluating single-agent temsirolimus (Torisel) in chemotherapy-naïve castration-resistant prostate cancer; results were post…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating sorafenib to overcome resistance to systemic chemotherapy in androgen-independent (castration-resistant) prostate…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: PS-341 Followed by Removal of Prostate for Those With Prostate Cancer [Phase 2]
A Phase 2 trial of PS-341 (bortezomib) followed by prostate removal in prostate cancer patients has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Prostate Mechanical Imager (PMI) Clinical Bridging Study
The clinical trial entry notes the completion of the Prostate Mechanical Imager (PMI) Clinical Bridging Study sponsored by Artann Laboratori…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer
This entry reports a completed clinical trial evaluating transperineal ultrasound for radiation therapy planning and image guidance in prost…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Laser Based Focal Ablation of Low Grade Prostate Cancer [NA]
A completed clinical trial from the University of Chicago evaluated laser-based focal ablation for low-grade prostate cancer.
-
FDA approval · 2014-03-25FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for Firmagon (degarelix) from Ferring Pharmaceuticals. The action updates the drug's labeling an…